AAAAAA
Results: 1-25/28
Authors:
LAPCHAK PA
Citation: Pa. Lapchak, A PRECLINICAL DEVELOPMENT STRATEGY DESIGNED TO OPTIMIZE THE USE OF GLIAL-CELL LINE-DERIVED NEUROTROPHIC FACTOR IN THE TREATMENT OF PARKINSONS-DISEASE, Movement disorders, 13, 1998, pp. 49-54
Authors:
LAPCHAK PA
ARAUJO DM
HILT DC
JIAO S
COLLIN F
MIYOSHI Y
YI A
ZHANG Z
GASH DM
Citation: Pa. Lapchak et al., TOPOGRAPHICAL DISTRIBUTION OF [I-125] GLIAL-CELL LINE-DERIVED NEUROTROPHIC FACTOR IN UNLESIONED AND MPTP-LESIONED RHESUS-MONKEY BRAIN FOLLOWING A BOLUS INTRAVENTRICULAR-INJECTION, Brain research, 789(1), 1998, pp. 9-22
Authors:
MIYOSHI Y
ZHANG ZM
OVADIA A
LAPCHAK PA
COLLINS F
HILT D
LEBEL C
KRYSCIO R
GASH DM
Citation: Y. Miyoshi et al., GLIAL-CELL LINE-DERIVED NEUROTROPHIC FACTOR-LEVODOPA INTERACTIONS ANDREDUCTION OF SIDE-EFFECTS IN PARKINSONIAN MONKEYS, Annals of neurology, 42(2), 1997, pp. 208-214
Authors:
ARAUJO DM
HILT DC
MILLER PJ
WEN D
JIAO S
LAPCHAK PA
Citation: Dm. Araujo et al., RET RECEPTOR TYROSINE KINASE IMMUNOREACTIVITY IS ALTERED IN GLIAL-CELL LINE-DERIVED NEUROTROPHIC FACTOR-RESPONSIVE NEURONS FOLLOWING LESIONS OF THE NIGROSTRIATAL AND SEPTOHIPPOCAMPAL PATHWAYS, Neuroscience, 80(1), 1997, pp. 9-16
Authors:
LAPCHAK PA
MILLER PJ
COLLINS F
JIAO S
Citation: Pa. Lapchak et al., GLIAL-CELL LINE-DERIVED NEUROTROPHIC FACTOR ATTENUATES BEHAVIORAL DEFICITS AND REGULATES NIGROSTRIATAL DOPAMINERGIC AND PEPTIDERGIC MARKERSIN 6-HYDROXYDOPAMINE-LESIONED ADULT-RATS - COMPARISON OF INTRAVENTRICULAR AND INTRANIGRAL DELIVERY, Neuroscience, 78(1), 1997, pp. 61-72
Authors:
LAPCHAK PA
MILLER PJ
JIAO S
Citation: Pa. Lapchak et al., GLIAL-CELL LINE-DERIVED NEUROTROPHIC FACTOR INDUCES THE DOPAMINERGIC AND CHOLINERGIC PHENOTYPE AND INCREASES LOCOMOTOR-ACTIVITY IN AGED FISCHER-344 RATS, Neuroscience, 77(3), 1997, pp. 745-752
Authors:
ZHANG ZM
MIYOSHI Y
LAPCHAK PA
COLLINS F
HILT D
LEBEL C
KRYSCIO R
GASH DM
Citation: Zm. Zhang et al., DOSE-RESPONSE TO INTRAVENTRICULAR GLIAL-CELL LINE-DERIVED NEUROTROPHIC FACTOR ADMINISTRATION IN PARKINSONIAN MONKEYS, The Journal of pharmacology and experimental therapeutics, 282(3), 1997, pp. 1396-1401
Authors:
LAPCHAK PA
GASH DM
COLLINS F
HILT D
MILLER PJ
ARAUJO DM
Citation: Pa. Lapchak et al., PHARMACOLOGICAL ACTIVITIES OF GLIAL-CELL LINE-DERIVED NEUROTROPHIC FACTOR (GDNF) - PRECLINICAL DEVELOPMENT AND APPLICATION TO THE TREATMENTOF PARKINSONS-DISEASE, Experimental neurology, 145(2), 1997, pp. 309-321
Authors:
BOWENKAMP KE
LAPCHAK PA
HOFFER BJ
MILLER PJ
BICKFORD C
Citation: Ke. Bowenkamp et al., INTRACEREBROVENTRICULAR GLIAL-CELL LINE-DERIVED NEUROTROPHIC FACTOR IMPROVES MOTOR FUNCTION AND SUPPORTS NIGROSTRIATAL DOPAMINE NEURONS IN BILATERALLY 6-HYDROXYDOPAMINE LESIONED RATS, Experimental neurology, 145(1), 1997, pp. 104-117
Authors:
LAPCHAK PA
GASH DM
JIAO SS
MILLER PJ
HILT D
Citation: Pa. Lapchak et al., GLIAL-CELL LINE-DERIVED NEUROTROPHIC FACTOR - A NOVEL THERAPEUTIC APPROACH TO TREAT MOTOR DYSFUNCTION IN PARKINSONS-DISEASE, Experimental neurology, 144(1), 1997, pp. 29-34
Authors:
GRANHOLM AC
MOTT JL
BOWENKAMP K
EKEN S
HENRY S
HOFFER BJ
LAPCHAK PA
PALMER MR
VANHORNE C
GERHARDT GA
Citation: Ac. Granholm et al., GLIAL-CELL LINE-DERIVED NEUROTROPHIC FACTOR IMPROVES SURVIVAL OF VENTRAL MESENCEPHALIC GRAFTS TO THE 6-HYDROXYDOPAMINE LESIONED STRIATUM, Experimental Brain Research, 116(1), 1997, pp. 29-38
Authors:
LAPCHAK PA
ARAUJO DM
HILT DC
SHENG J
JIAO SS
Citation: Pa. Lapchak et al., ADENOVIRAL VECTOR-MEDIATED GDNF GENE-THERAPY IN A RODENT LESION MODELOF LATE-STAGE PARKINSONS-DISEASE, Brain research, 777(1-2), 1997, pp. 153-160
Authors:
LAPCHAK PA
JIAO SS
COLLINS F
MILLER PJ
Citation: Pa. Lapchak et al., GLIAL-CELL LINE-DERIVED NEUROTROPHIC FACTOR - DISTRIBUTION AND PHARMACOLOGY IN THE RAT FOLLOWING A BOLUS INTRAVENTRICULAR-INJECTION, Brain research, 747(1), 1997, pp. 92-102
Authors:
ANGRIST M
BOLK S
HALUSHKA M
LAPCHAK PA
CHAKRAVARTI A
Citation: M. Angrist et al., GERMLINE MUTATIONS IN GLIAL-CELL LINE-DERIVED NEUROTROPHIC FACTOR (GDNF) AND RET IN A HIRSCHSPRUNG DISEASE PATIENT, Nature genetics, 14(3), 1996, pp. 341-344
Authors:
LAPCHAK PA
MILLER PJ
JIAO SS
ARAUJO DM
HILT D
COLLINS F
Citation: Pa. Lapchak et al., BIOLOGY OF GLIAL-CELL LINE-DERIVED NEUROTROPHIC FACTOR (GDNF) - IMPLICATIONS FOR THE USE OF GDNF TO TREAT PARKINSONS-DISEASE, Neurodegeneration, 5(3), 1996, pp. 197-205
Authors:
JIAO SS
MILLER PJ
LAPCHAK PA
Citation: Ss. Jiao et al., ENHANCED DELIVERY OF [I-125] GLIAL-CELL LINE-DERIVED NEUROTROPHIC FACTOR TO THE RAT CNS FOLLOWING OSMOTIC BLOOD-BRAIN-BARRIER MODIFICATION, Neuroscience letters, 220(3), 1996, pp. 187-190
Authors:
BOWENKAMP KE
LAPCHAK PA
HOFFER BJ
BICKFORD PC
Citation: Ke. Bowenkamp et al., GLIAL-CELL LINE-DERIVED NEUROTROPHIC FACTOR REVERSES MOTOR IMPAIRMENTIN 16-17-MONTH-OLD RATS, Neuroscience letters, 211(2), 1996, pp. 81-84
Authors:
LAPCHAK PA
JIAO SS
MILLER PJ
WILLIAMS LR
CUMMINS V
INOUYE G
MATHESON CR
YAN Q
Citation: Pa. Lapchak et al., PHARMACOLOGICAL CHARACTERIZATION OF GLIAL-CELL LINE-DERIVED NEUROTROPHIC FACTOR (GDNF) - IMPLICATIONS FOR GDNF AS A THERAPEUTIC MOLECULE FOR TREATING NEURODEGENERATIVE DISEASES, Cell and tissue research, 286(2), 1996, pp. 179-189
Authors:
WANG Y
TIEN LT
LAPCHAK PA
HOFFER BJ
Citation: Y. Wang et al., GDNF TRIGGERS FIBER OUTGROWTH OF FETAL VENTRAL MESENCEPHALIC GRAFTS FROM NIGRA TO STRIATUM IN 6-OHDA-LESIONED RATS, Cell and tissue research, 286(2), 1996, pp. 225-233
Authors:
GASH DM
ZHANG ZM
OVADIA A
CASS WA
YI A
SIMMERMAN L
RUSSELL D
MARTIN D
LAPCHAK PA
COLLINS F
HOFFER BJ
GERHARDT GA
Citation: Dm. Gash et al., FUNCTIONAL RECOVERY IN PARKINSONIAN MONKEYS TREATED WITH GDNF, Nature, 380(6571), 1996, pp. 252-255
Authors:
ARAUJO DM
LAPCHAK PA
Citation: Dm. Araujo et Pa. Lapchak, INDUCTION OF IMMUNE-SYSTEM MEDIATORS IN THE HIPPOCAMPAL-FORMATION IN ALZHEIMERS AND PARKINSONS DISEASES - SELECTIVE EFFECTS ON SPECIFIC INTERLEUKINS AND INTERLEUKIN RECEPTORS, Neuroscience, 61(4), 1994, pp. 745-754
Authors:
LAPCHAK PA
ARAUJO DM
HEFTI F
Citation: Pa. Lapchak et al., EFFECTS OF CHRONIC NERVE GROWTH-FACTOR TREATMENT ON HIPPOCAMPAL [H-3]CYTISINE NICOTINIC BINDING-SITES AND PRESYNAPTIC NICOTINIC RECEPTOR FUNCTION FOLLOWING FIMBRIAL TRANSECTIONS/, Neuroscience, 60(2), 1994, pp. 293-298
Authors:
LAPCHAK PA
ARAUJO DM
Citation: Pa. Lapchak et Dm. Araujo, NGF SUPPRESSION OF WEIGHT-GAIN IN ADULT FEMALE RATS CORRELATES WITH DECREASED HYPOTHALAMIC CHOLECYSTOKININ LEVELS, Brain research, 655(1-2), 1994, pp. 12-16
Authors:
LAPCHAK PA
ARAUJO DM
Citation: Pa. Lapchak et Dm. Araujo, EFFECTS OF CHRONIC INTRAVENTRICULAR NERVE GROWTH-FACTOR TREATMENT ON VASOACTIVE-INTESTINAL-PEPTIDE AND NEUROPEPTIDE-Y LEVELS IN THE HIPPOCAMPAL-FORMATION AND CEREBRAL-CORTEX FOLLOWING FIMBRIAL TRANSECTIONS, Brain research, 654(1), 1994, pp. 1-7
Authors:
LAPCHAK PA
ARAUJO DM
CARSWELL S
HEFTI F
Citation: Pa. Lapchak et al., DISTRIBUTION OF [I-125] NERVE GROWTH-FACTOR IN THE RAT-BRAIN FOLLOWING A SINGLE INTRAVENTRICULAR-INJECTION - CORRELATION WITH THE TOPOGRAPHICAL DISTRIBUTION OF TRKA MESSENGER RNA-EXPRESSING CELLS, Neuroscience, 54(2), 1993, pp. 445-460